Literature DB >> 24438978

Complete pathologic response after neoadjuvant treatment with vemurafenib for malignant melanoma.

Orit Kaidar-Person1, Ayelet Eran2, Gil Bar-Sela3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24438978     DOI： 10.1016/j.jaad.2013.09.052

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  1 in total

1.  Neoadjuvant BRAF-targeted therapy in regionally advanced and oligometastatic melanoma.

Authors:  Zeynep Eroglu; Jennifer Eatrides; Syeda Mahrukh Hussnain Naqvi; Youngchul Kim; Jeani Rich; Nalan Akgul Babacan; Andrew S Brohl; Joseph Markowitz; Amod Sarnaik; Jonathan Zager; Nikhil I Khushalani; Vernon K Sondak; Jane Messina
Journal:  Pigment Cell Melanoma Res       Date:  2019-09-12       Impact factor: 4.693
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.